Explore the World of Cannabis
Tahoe Fire by
Five Legged Goat
Lavender Kush
by StRa
Crazy Kush
by Highersolutions
Frisian Dew by
Euchrid-Eucrow

THC

How to stay safe vaping THC

Vaping THC, or tetrahydrocannabinol, has become increasingly popular in recent years. THC is the psychoactive compound found in marijuana that produces the “high” sensation. While vaping THC may seem like a safer alternative to smoking it, there are still risks involved.

Most importantly, vaping THC can lead to several health risks, including lung damage, respiratory issues, and addiction. Vaping THC can lead to several cases of acute illness.

Users with the lung disease COPD should be warned that it can worsen their condition.

Vaping cannabis can lead to “e-cigarette or vaping associated lung injury,” or EVALI if vitamin E acetate… Continue reading

Weed Biofactories


Imagine a steel vat filled with healthy, organic yeast creating THC, CBDs and other cannabinoids as their waste byproduct, which is harvested for both medical and recreational use.

This is now, not the future. Cannabis entrepreneurs have suddenly been flooded with tons of investment money and are using scientific research to find new ways of increasing production yields, improving quality, and to continue providing cannabis-based products to the ever-expanding marketplace.

The push is on to satisfy the millions of users in newly legal states in the USA, and around the world. In recent years the use of CBDs for medical… Continue reading

Study: Synthetic THC Kills Leukemia Cells

leukemia

Tubingen, Germany: The administration of FDA-approved synthetic THC (dronabinol) induces death in leukemia cell lines and offers a “low-toxic therapy option” for patients with cancer, according to findings published online in the journal BMC Cancer.

German researchers evaluated the impact of dronabinol on leukemia cells. Investigators reported that synthetic THC displayed “remarkable anti-proliferative as well as pro-apoptopic efficacy … in a broad spectrum of acute leukemia cell lines.” These findings “provide a promising rationale for the clinical use of cannabinoids … in distinct entities of acute leukemia,” they concluded.

Preclinical data dating back over four decades has consistently documented the… Continue reading